These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3381577)

  • 1. [Effectiveness of prophylactic inoculations against cutaneous leishmaniasis].
    Dobrzhanskaia RS; Khuseĭinova KhKh; Sukhanov TA; Saf'ianova VM; Emel'ianova LP
    Vestn Dermatol Venerol; 1988; (3):15-20. PubMed ID: 3381577
    [No Abstract]   [Full Text] [Related]  

  • 2. Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease.
    Lira R; Méndez S; Carrera L; Jaffe C; Neva F; Sacks D
    Exp Parasitol; 1998 Jul; 89(3):331-42. PubMed ID: 9676711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility to and the characteristics of the course of experimental leishmaniasis in different species of mammals infected with Leishmania major, L. turanica and L. gerbilli].
    Strelkova MV
    Med Parazitol (Mosk); 1991; (1):35-9. PubMed ID: 2067472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Attempt at cryogenic preservation of the amastigote stage of Leishmania major in the ear skin of experimentally infected golden hamsters (Mesocricetus auratus)].
    Passova OM; Rakhimov KhT
    Med Parazitol (Mosk); 1986; (4):45-6. PubMed ID: 3762496
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the virulence and immunogenicity of vaccinal strains of Leishmania major, preserved by freezing in liquid nitrogen].
    Khuseĭinova KhKh; Saf'ianova VM; Dobrazhanskaia RS; Khairulin FIa; Emel'ianova LP
    Vestn Dermatol Venerol; 1985 Jul; (7):20-4. PubMed ID: 4050086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the virulent properties of strains of the causative agent of zoonotic cutaneous leishmaniasis in passage via Phlebotomus papatasi].
    Strelkova MV; Alekseev AN; Passova OM
    Med Parazitol (Mosk); 1981; 50(6):19-23. PubMed ID: 7322023
    [No Abstract]   [Full Text] [Related]  

  • 7. Experiences with vaccines against cutaneous leishmaniasis: of men and mice.
    Modabber F
    Parasitology; 1989; 98 Suppl():S49-60. PubMed ID: 2657601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of immunity in cutaneous leishmaniasis. I. Comparison of the immunizing effect of strains of Leishmania tropica major of different virulence].
    Kellina OI
    Med Parazitol (Mosk); 1966; 35(4):455-62. PubMed ID: 5993837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative characteristics of Leishmania tropica major from patients with zoonotic cutaneous leishmaniasis from vaious foci in Turkmenia and Uzbekistan].
    Khuseĭinova KhKh; Kellina OI
    Med Parazitol (Mosk); 1974; 43(6):655-63. PubMed ID: 4281051
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new vaccination procedure against cutaneous leishmaniasis.
    Vouldoukis I; Frommel D; Ogunkolade BW; Monjour L
    Ann Trop Med Parasitol; 1989 Dec; 83(6):645-6. PubMed ID: 2619382
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental proof of the heterogeneous composition of natural Leishmania major populations for the virulence trait].
    Kellina OI; Passova OM; Alekseev AN
    Med Parazitol (Mosk); 1981; 50(6):4-11. PubMed ID: 7322024
    [No Abstract]   [Full Text] [Related]  

  • 13. Leishmania transmission-blocking vaccines: a review.
    Tonui WK
    East Afr Med J; 1999 Feb; 76(2):93-6. PubMed ID: 10442130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major.
    Mitchell GF; Handman E; Spithill TW
    Int J Parasitol; 1985 Dec; 15(6):677-84. PubMed ID: 4093239
    [No Abstract]   [Full Text] [Related]  

  • 15. Leishmania infecting man and wild animals in Saudi Arabia. 7. Partial protection of mice against Leishmania major by prior infection with L. arabica.
    Neal RA; Reeves A; Peters W
    Trans R Soc Trop Med Hyg; 1990; 84(2):233-8. PubMed ID: 2389313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W; Forberg K; Kammerer E; Bogdan C; Röllinghoff M
    J Immunol; 1986 Jul; 137(2):702-7. PubMed ID: 3487578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the antigenic properties and virulence of Leishmania clones (Trypanosomatidae, Leishmania)].
    Emel'ianova LP; Saf'ianova VM
    Parazitologiia; 1982; 16(6):445-51. PubMed ID: 7155626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological parameters of visceral leishmaniasis of Leishmania major-infected golden hamsters.
    Goto H; Carneiro Leao R; Ribeiro da Mata VL; Hatsumi Yamashiro E; Seixas Duarte MI
    Allergol Immunopathol (Madr); 1987; 15(6):349-53. PubMed ID: 3445875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The present and future of vaccination for cutaneous leishmaniasis.
    Greenblatt CL
    Prog Clin Biol Res; 1980; 47():259-85. PubMed ID: 7010374
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative study of the Kabul strain of Leishmania tropica and the causative agent of the Iraqi and Central Asian forms of cutaneous leishmaniasis].
    Kellina OL; Passova OM
    Med Parazitol (Mosk); 1974; 43(1):73-82. PubMed ID: 4282111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.